Cadence Pharmaceuticals reports 4Q loss (AP)
{ Posted on Mar 15 2010 by Yahoo! Finance: Earnings News }
Cadence Pharmaceuticals Inc. on Monday reported a fourth quarter loss on higher expenses related to a pain and fever drug that has yet to receive government approval.
Unique in the industry, Macroaxis financial engineering platform delivers measurable value in the form of improved return on your investment portfolios | 

